دورية أكاديمية

Progress toward measles preelimination--African Region, 2011-2012.

التفاصيل البيبلوغرافية
العنوان: Progress toward measles preelimination--African Region, 2011-2012.
المؤلفون: Masresha BG, Kaiser R, Eshetu M, Katsande R, Luce R, Fall A, Dosseh AR, Naouri B, Byabamazima CR, Perry R, Dabbagh AJ, Strebel P, Kretsinger K, Goodson JL, Nshimirimana D
مؤلفون مشاركون: Centers for Disease Control and Prevention (CDC)
المصدر: MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2014 Apr 04; Vol. 63 (13), pp. 285-91.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: U.S. Centers for Disease Control Country of Publication: United States NLM ID: 7802429 Publication Model: Print Cited Medium: Internet ISSN: 1545-861X (Electronic) Linking ISSN: 01492195 NLM ISO Abbreviation: MMWR Morb Mortal Wkly Rep Subsets: MEDLINE
أسماء مطبوعة: Publication: Atlanta, GA : U.S. Centers for Disease Control
Original Publication: [Atlanta] U. S. Dept. of Health, Education, and Welfare, Public Health Service, Center for Disease Control.
مواضيع طبية MeSH: Disease Eradication* , Population Surveillance*, Measles/*epidemiology , Measles/*prevention & control, Africa/epidemiology ; Genotype ; Humans ; Immunization Programs ; Incidence ; Measles Vaccine/administration & dosage ; Measles virus/genetics ; Vaccination/statistics & numerical data
مستخلص: In 2008, the 46 member states of the World Health Organization (WHO) African Region (AFR) adopted a measles preelimination goal to reach by the end of 2012 with the following targets: 1) >98% reduction in estimated regional measles mortality compared with 2000, 2) annual measles incidence of fewer than five reported cases per million population nationally, 3) >90% national first dose of measles-containing vaccine (MCV1) coverage and >80% MCV1 coverage in all districts, and 4) >95% MCV coverage in all districts by supplementary immunization activities (SIAs). Surveillance performance objectives were to report two or more cases of nonmeasles febrile rash illness per 100,000 population, one or more suspected measles cases investigated with blood specimens in ≥80% of districts, and 100% completeness of surveillance reporting from all districts. This report updates previous reports and describes progress toward the measles preelimination goal during 2011-2012. In 2012, 13 (28%) member states had >90% MCV1 coverage, and three (7%) reported >90% MCV1 coverage nationally and >80% coverage in all districts. During 2011-2012, four (15%) of 27 SIAs with available information met the target of >95% coverage in all districts. In 2012, 16 of 43 (37%) member states met the incidence target of fewer than five cases per million, and 19 of 43 (44%) met both surveillance performance targets. In 2011, the WHO Regional Committee for AFR established a goal to achieve measles elimination by 2020. To achieve this goal, intensified efforts to identify and close population immunity gaps and improve surveillance quality are needed, as well as committed leadership and ownership of the measles elimination activities and mobilization of adequate resources to complement funding from global partners.
References: MMWR Morb Mortal Wkly Rep. 2009 Sep 25;58(37):1036-41. (PMID: 19779399)
MMWR Morb Mortal Wkly Rep. 2011 Apr 1;60(12):374-8. (PMID: 21451448)
J Infect Dis. 2011 Jul;204 Suppl 1:S198-204. (PMID: 21666162)
Wkly Epidemiol Rec. 2014 Feb 7;89(6):45-52. (PMID: 24524163)
معلومات مُعتمدة: 001 International WHO_ World Health Organization
المشرفين على المادة: 0 (Measles Vaccine)
تواريخ الأحداث: Date Created: 20140405 Date Completed: 20140513 Latest Revision: 20220129
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC5779352
PMID: 24699765
قاعدة البيانات: MEDLINE